logo

Acadia Pharmaceuticals Inc (ACAD)



Trade ACAD now with
  Date
  Headline
3/3/2020 6:01:44 PM ACADIA Pharma, Neuren Pharma Announce RPD Designation For Trofinetide For Treatment Of Rett Syndrome
12/4/2019 8:53:27 PM ACADIA Presents Positive Results On Pimavanserin In Patients With Dementia-Related Psychosis
9/9/2019 6:41:29 AM ACADIA Says Phase 3 HARMONY Study Met Its Primary Endpoint
7/22/2019 4:11:22 PM ACADIA: Pimavanserin Didn't Achieve Statistical Significance On Primary Endpoint
5/18/2019 1:41:07 PM ACADIA To Present Phase 2 CLARITY Results For Pimavanserin As Adjunctive Treatment In Major Depressive Disorder
4/25/2019 9:04:17 AM ACADIA Pharmaceuticals Begins Phase 3 CLARITY Program
4/1/2019 9:05:39 AM ACADIA Promotes Elena Ridloff To EVP, CFO
11/30/2018 4:06:32 PM ACADIA Pharmaceuticals Announces Closing Of Public Offering Of Common Stock
11/27/2018 9:32:28 PM ACADIA Pharma Prices Underwritten Public Offering Of 16.18 Mln Shares At $17.00/shr
10/31/2018 6:44:45 AM ACADIA Pharma Announces Positive Top-line Results From Phase 2 CLARITY Trial Of Pimavanserin
8/8/2018 4:15:02 PM ACADIA Pharma Q2 Loss/share $0.51 Vs. Loss $0.55 Year Ago
7/19/2018 4:09:04 PM ACADIA Pharmaceuticals Appoints Austin Kim As EVP, General Counsel And Secretary
  
 
>